Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER) (MOSER)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Ramesh Venkataraman, Indian Society of Critical Care Medicine
ClinicalTrials.gov Identifier:
NCT01346735
First received: May 2, 2011
Last updated: August 30, 2016
Last verified: August 2016

May 2, 2011
August 30, 2016
August 2011
October 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01346735 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)
Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)

Most literature on ICU infections and the resistant patterns comes from the western literature. This data may not truly reflect the incidence, epidemiology and resistance patterns in developing countries such as India. However, empiric antibiotic therapy is generally initiated using western guidelines. This can potentially lead to inadequate, inappropriate and ineffective empiric antibiotic therapy for ICU infections in the Indian setting. Hence in this multi-center observational study, we seek to:

  1. To determine the incidence of ICU-related infections (VAP, CAUTI and CRBSI) in India
  2. To explore the microbiology, resistance and treatment patterns of these infections
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Adult ICU patients
Nosocomial Infections
Other: No intervention
ICU infections
Infections acquired during the ICU stay
Intervention: Other: No intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
381
October 2012
October 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. ICU stay >48 hours
  2. One of the following infections (VAP, CAUTI or CRBSI)

Exclusion Criteria:

  1. Index ICU stay < 48 hours
  2. Re-admissions to the ICU within the same hospitalization
  3. Age >18 years or <70 years
  4. Known HIV serology positivity
  5. Burns
  6. Solid organ or Bone-marrow transplant
  7. No ICU-acquired infections (specifically VAP, CAUTI and CRBSI)
Both
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
India
 
NCT01346735
ISCCM1
Yes
Not Provided
Not Provided
Dr. Ramesh Venkataraman, Indian Society of Critical Care Medicine
Indian Society of Critical Care Medicine
Not Provided
Not Provided
Indian Society of Critical Care Medicine
August 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP